ETV6 and acute lymphoblastic leukemia: Firstly, it was reported to be approximately 20‐fold up‐regulation in pediatric ALL cases resistance to vincristine and daunorubicin,30 and was also distinguished expressed in TEL/AML1 ALL subgroups, this will lead to good outcomes.